Fusion Guided Biopsies Promise Improved Prostate Cancer Diagnosis

New technology combines MRI, ultrasound for better resultsĀ 

Fusion guided biopsy shows better image for prostate cancer diagnosis

Fusion guided biopsies could potentially lead to better diagnoses of prostate cancer and fewer repeat biopsies.

A new cancer-fighting tool is now available to help detect prostate cancer, and it’s currently being used at the Cleveland Clinic to examine patients in the biopsy procedure room. It’s called fusion guided biopsy, and it uses a mixture of MRI and ultrasound in order to provide better results for doctors and patients.

Fusion guided biopsies work by combining MRI scans with live, real-time ultrasound images of the prostate. After a patient undergoes a scan and a radiologist reviews it for suspicious areas, an ultrasound probe is inserted into the patient, and the fusion software shifts the MRI image accordingly and gives a detailed 3-D ultrasound/MRI view. Doctors can then use the fused image to guide biopsy needles directly to the area that’s needed for sampling, reducing the “randomness” of current prostate biopsies.

To read more on fusion guided biopsies, click here: Fusion Guided Biopsy: A Smarter Way to Look for Prostate Cancer.

For more than 30 years, Havel’s has offered premium quality biopsy needles and surgical scalpel blades to doctors, hospitals and other leading medical professionals. To see Havel’s selection of biopsy needles and surgical scalpel blades, please click here: Havel’s Biopsy Needles and Surgical Scalpel Blades.

 

Related articles:

 

Be Sociable, Share!
This entry was posted in Biopsy, Biopsy Needles, Cancer, Technology and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *